• Medientyp: E-Artikel
  • Titel: SARS-CoV-2-assoziierte Todesfälle innerhalb des ersten Jahres der COVID-19-Pandemie: eine Autopsiestudie SARS-CoV-2-associated fatalities within the first year of the COVID-19 pandemic: an autopsy study
  • Beteiligte: Autsch, Angelina; Ihle, Hannah; Kleemann, Sandra; Sanft, Juliane; Hahnemann, Maria; Hubig, Michael; Philipp, Mike; Bauer, Michael; Deinhardt-Emmer, Stefanie; Gaßler, Nikolaus; Mall, Gita; Wittschieber, Daniel
  • Erschienen: Springer Science and Business Media LLC, 2023
  • Erschienen in: Rechtsmedizin
  • Sprache: Englisch
  • DOI: 10.1007/s00194-023-00636-x
  • ISSN: 0937-9819; 1434-5196
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>COVID-19 now exists for more than 3 years and has caused almost 7 million deaths worldwide. At the beginning of this study only little was known on the patients’ characteristics and comparative autopsy studies are still rare.</jats:p> </jats:sec><jats:sec> <jats:title>Material and methods</jats:title> <jats:p>Between 11 March 2020 and 10 March 2021, 55 consecutive and complete autopsies of individuals who died in association with SARS-CoV‑2 infections were performed shortly after death (median PMI 6.8 h) by the same team. Clinical data were available in 45 of 55 cases. 1st vs. 2nd infection wave cases and male vs. female cases were compared.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>Thirty-five patients were male (63.6%) 20 were female (36.4%), average age 72.4 years. Seventeen cases (30.9%) could be assigned to the 1st and 38 cases (69.1%) to the 2nd infection wave. Forty-two of the decedents (76.4%) died due to COVID-19. Arterial hypertension, obesity, and cardiac hypertrophy were the most frequent detected comorbidities.</jats:p> </jats:sec><jats:sec> <jats:title>Discussion</jats:title> <jats:p>The present study corroborates previous research data but also reveals new approaches for further comparative studies. Patient-specific personal and general ICU-related risk factors for the development of thromboembolisms oppose the effects of changes in anticoagulant medication.</jats:p> </jats:sec>